News Solid Biosciences acquires AavantiBio, conducts $75 million ... The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a
News FDA says comparator dose scuppered Moderna's flu jab filing The FDA has defended its decision to issue a refusal-to-file (RTF) letter for Moderna's new mRNA-based influenza vaccine.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
